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Abstract: To deliver on the promise of cardiac regeneration, an integration process between an
emerging field, nanomedicine, and a more consolidated one, tissue engineering, has begun. Our work
aims at summarizing some of the most relevant prevailing cases of nanotechnological approaches
applied to tissue engineering with a specific interest in cardiac regenerative medicine, as well as
delineating some of the most compelling forthcoming orientations. Specifically, this review starts with
a brief statement on the relevant clinical need, and then debates how nanotechnology can be combined
with tissue engineering in the scope of mimicking a complex tissue like the myocardium and its
natural extracellular matrix (ECM). The interaction of relevant stem, precursor, and differentiated
cardiac cells with nanoengineered scaffolds is thoroughly presented. Another correspondingly
relevant area of experimental study enclosing both nanotechnology and cardiac regeneration, e.g.,
nanoparticle applications in cardiac tissue engineering, is also discussed.
Keywords: nanomaterial; extracellular matrix; cardiac cells; cardiac regeneration; hybrid materials;
tissue engineering
1. Introduction: Clinical Need
Heart disease is a priority area for regenerative medicine, accounting for more than 30% of
all deaths including the main three clinical syndromes, ischaemic heart disease (IHD), stroke, and
peripheral ischaemic disease. Even though frequency in the developed countries tends to decrease,
this is balanced by its rise in the developing world. Indeed, the World Health Organization (WHO)
reported that, in 2016, ischaemic heart disease was still the most common cause of mortality worldwide
accounting for about 9.4 million deaths [1]. In a large portion of patients, IHD first shows itself
as an acute myocardial infarction (AMI), conceivably resulting in sudden death or causing heart
failure (HF) during the subsequent chronic stage. Indeed, infarct of the myocardium represents the
biggest reason of HF all over the world, and HF is heavily related to the quantity of compromised
tissue portion subsequent to acute ischaemia/reperfusion [2]. The scarce regenerative potential of the
human myocardium causes a failure in reestablishing the correct cardiomyocyte (CM) cell numbers
and in counteracting the formation of scarred tissue, a situation often leading to arrhythmic events,
altered pumping activity and HF. In spite of current pharmacological approaches and interventional
therapies, the morbidity and mortality of patients with seriously compromised ventricular function
following AMI remain very high. Ventricular assist devices represent a great accomplishment of
current medicine, thanks to their ability to supply temporary functional aid to failing organs on the
road to transplantation. They do not represent, however, a permanent answer to the problem, as they
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show supplementary disadvantages connected for example with augmented haemostatic occurrence,
bleeding events and risks of infection. Another critical aspect is that these mechanical devices are
not endowed with the ability to adapt to the changeable patient’s metabolic requests. At present, the
unique long-lasting therapeutic intervention for severe HF remains organ transplantation, however
the actual donation rates fall widely below population needs, including nations where transplant rates
are the highest.
As an answer to this unmet need, in the last twenty years possible approaches pointing to
regenerate the damaged heart consequent to AMI have represented object of focused fundamental [3]
and translational research [4]. Regrettably, therapeutic options in the area of cardiac regeneration,
widely founded on cell implantation, have thus far given up disappointing results [5,6].
To overcome the limit of the therapeutic effectiveness of stem cells (SCs) transplantation (i.e., low
survival, retention/engraftment, homing, and differentiation) some strategies have been attempted
such as preconditioning, genetic modification, co-transplantation with bioactive factors, and tissue
engineering aimed at modifying cell behaviour and favouring cell differentiation, as already reviewed
by Chen’s group in the case of mesenchymal stem cells (MSCs) [7]. Tissue engineering is defined as
“the application of principles and methods of engineering and life sciences toward the fundamental
understanding of structure–function relationships in normal and pathological mammalian tissues
and the development of biological substitutes to restore, maintain or improve tissue function” [8].
In particular, “myocardial tissue engineering” (MTE) is considered one of the most promising
strategies to efficiently treat cardiac disorders and involves various approaches for the generation of
three-dimensional myocardium-like constructs that should provide mechanical support to damaged
myocardial tissue and mainly instructs stem cell, both seeded and in situ recruited, towards a
correct morphogenesis.
However, these strategies should be still optimized to achieve clinical safety. On the other
hand, acellularized or cellularized nanomaterial-based therapy provides promising opportunities to
overcome the limitations related to the SCs implantation and tissue regeneration.
Various studies demonstrated that scaffolds provided not only a suitable mechanical support
to cell culture, but they can also regulate SC behaviour by favouring SC survival, proliferation
and differentiation, and providing a guide for tridimensional (3D) tissue reconstruction [9–11]. In
fact, various studies showed that differentiation occurred either in the presence [12–16] or in the
absence [9,17–19] of external stimuli when SCs have been cultured on biomaterials. In particular,
the exclusion of exogenous factors allowed to demonstrate that an enhanced differentiation could be
driven by the physical, chemical, and biological properties of biomaterials.
A strategy capable of stimulating the regeneration of myocardium accompanied by a protective
effect to prevent its maladaptive remodeling would lead to an efficient therapeutic action. To deliver on
these promises for heart disease, one must have reliable means for working at the nanoscale, exploiting
nanoengineering to generate complex tissues like the myocardium.
Here, we overview the recent nanotechnological applications combined with tissue engineering
to the scope of mimicking a complex tissue like the myocardium and its natural extracellular matrix
(ECM) and highlights how the versatility of nanomaterials can be exploited to favour the interaction of
relevant stem, precursor, and differentiated cardiac cells with nanoengineered scaffolds to advance
cardiac regeneration.
2. Cardiac ECM as a Guide to Nanoengineering
In a developing organ, the 3D network constituted by ECM drives its initial complexity. Thus,
reproducing the ECM will help to recapitulate complexity in tissue engineering. ECM is endowed with
a complicated arrangement of many structural proteins with nanoscale features including collagen
and fibronectin, proteoglycans, and glycoproteins as well as soluble substances including growth
factors (Figure 1). It not only provides a framework for cell to ECM and cell to cell interactions,
but also regulates some important cellular functions such as adhesion and growth. During the past
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several years, an improved ability to manufacture a genuine biomimetic microenvironment came from
production of innovative synthetic nanosystems and from their assembly into current macro- and
microscale matrices. More recently, it became apparent that nanocomposites can help in overcoming
matrix limitations in current biomaterials [20].
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Figure 1. Representation of the complex tridimensional structure of the cardiac extracellular matrix
(ECM). ECM is made of a dense network of proteins such as elastin, collagens, proteoglycans and
glycoproteins. Through proteins such as fibronectins, laminins, cadherins and integrins, ECM plays
a key role in cellular functions such as cell adhesion and growth thanks to the presence of soluble
substances including growth factors.
The elastic heart wall consists of compacted fibrillar collagen and elastin bundles forming a
tight network which ranges from ten to several hundreds of nanometers across. Fibronectin and
laminin, proteins with nanoscale features and adhesive properties, completely cover this elastic mesh,
allowing cells to surface adhere through integrins and cadherins (Figure 1) [21]. Conceptually, the
myocardial ECM can be classified into elements residing in the interstitial matrix (collagen I, collagen
III, and fibronectin) and residing in the highly organized sheet-like layer of ECM known as basement
membrane (collagen IV, V, VII, X, and XIV and laminin) which plays a central contribution in sarcomere
assembly through interactions with integrins [22].
A pioneering study by Ott and colleagues in 2008 emphasized the importance of the ECM in
engineering a bioartificial rat heart by guiding morphological organization and essential physiological
functions [23]. This study started with the detergent-based decellularization of adult rat hearts through
coronary perfusion, which allowed for the preservation of the underlying ECM. Upon reseeding
with cells of the myocardial and endothelial lineages, the ECM sustained self-organization leading
to restored pump function. On the other hand, when the same cells were seeded on a flat scaffold, a
random cellular distribution was observed and CMs lost their elongated morphology, resulting in a
compromised physiological function.
Another group demonstrated that also SCs differentiate towards myocardial phenotype when
cultured on decellularized human cardiac ECM slices, obtained from cardiac samples taken from
patients. There was an increased expression of cardiac transcription factors and sarcomeric proteins
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in both embryonic stem cells (ESC) and induced pluripotent stem cells (iPSCs), while ECM failed to
induce MSC differentiation [24]. On the contrary, Matrigel and Geltrex did not promote the expression
of cardiac markers in any type of cells [24].
Stem cell niches provide spatial and temporal signals, which control SC behaviour such as
self-renewal, differentiation and therefore cell fate and indeed, niches are composed of ECM components,
soluble factors, and supportive cells [25].
These works demonstrated that microenvironment is essential to induce an efficient differentiation
of SCs towards cardiac lineage, thereby engineered nanostructured scaffolds must recreate the
characteristics of the native tissue by mimicking the physical and biological features of the ECM to
achieve the regeneration of cardiac tissue.
3. Nanopatterning Technologies for Cardiac Tissue Regeneration
3.1. Micro-Nanotopography
The optimization of surface micro and nano topography mimicking anisotropic structure of the
myocardium is fundamental to provide a spatial interface to control adhesion, elongation, ordered
disposition and myocardial commitment of SCs. Some representative examples of nanomaterials and
their relevant biological effects are summarized in Table 1. Micro and nanofabrication methods allowed
to transfer the information at these scales in a controlled, predefined, and versatile way (Figure 2a) [26].
Optical lithography was used to direct the attachment of cardiac cells cultured on surfaces, having
a patterning with 20-µm wide lines, to control the morphology and microtubule density of cardiac
myocytes [27]. Methacrylated tropoelastin (MeTro) coating by means microfluidic method allowed
the neonatal rat CMs attachment and beating [28]. Soft lithography consented to fabricate arrays at
level of nanoscale using poly(ethylene glycol) (PEG) hydrogel [29]. Nanofabric mimicking ECM and
containing fibronectin, laminin, collagen type I and collagen type II was obtained by soft lithography.
Through this technique a nanotopography with nanopillars and nanogrooves allowed the control of
SC differentiation including beating CMs. This is a promising but still very immature study which
faces many problems that need to be addressed (for example homogeneity) [30].
Nanomaterials 2020, 10, 1587 5 of 28
Nanomaterials 2020, 10, x FOR PEER REVIEW 5 of 29 
 
 
Figure 2. Representation of different micro-nanoengineering approaches to develop scaffolds 
recapitulating the complex signals necessary for cardiac regeneration. (a) Micro-nanofabrication 
techniques are crucial to produce scaffolds mimicking the anisotropic micro-nanostructure and 
mechanical properties of native cardiac ECM; (b) Micro-nanostructured scaffolds based on 
non-biodegradable and/or biodegradable polymers were further implemented by incorporating 
electrically conductive nanomaterials to provide relevant electro-mechanical stimulation. 
Implementing cardiac patch with drug delivery systems using different methods can help to treat 
simultaneously myocardial ischemia-reperfusion, to prevent left ventricular remodeling and to 
induce cardiac regeneration processes. 
Figure 2. Representation of different micro-nanoengineering approaches to develop scaffolds
recapitulating the complex signals necessary for cardiac regeneration. (a) Micro-nanofabrication
techniques are crucial to produce scaffolds mimicking the anisotropic micro-nanostructure and
mechanical properties of native cardiac EC ; (b) icro-nanostructured scaffolds based on
non-biodegradable and/or biodegradable poly ers were further i ple ented by incorporating
electrically conductive nanomaterials to provide relevant electro-mechanical stimulation. Implementing
cardiac patch with drug delivery systems using different methods can help to treat simultaneously
myocardial ischemia-reperfusion, to prevent left ventricular remodeling and to induce cardiac
regeneration processes.
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Table 1. Representative examples of scaffold materials, cells and micro-nanofabrication techniques for myocardial tissue engineering (MTE) with their relevant
biological effects.
Material NM Cells Approaches/Method ofAssembly Specific Application Biological Effects Ref.
GelMA and MeTro neonatal rat CMs Micromolding,photolithography in vitro MTE Cell attachment and beating [28]
PEG CMs Soft lithography in vitro MTE Alignment of the focal adhesions [29]
PS Human AM-MSCs +mouse ESCs Soft lithography in vitro MTE
Early differentiation of mESCs (in cardiac-like
beating cells) and heterogeneous cells [30]
Agarose C2C12 Laser ablation in vitro MTE Improved attachment and differentiation ofmyoblasts [31]
PGS neonatal rat CMs Laser-assisted technique in vitro MTE Increased alignment of heart cells andimproved mechanical properties [32,33]
PHB MSCs, CMs, CFs Electrospinning in vitro MTE Induced angiogenesis, reparative process andremodeling [34]
PLGA neonatal rat CMs Plasma etching, adsorptionfibronectin in vitro MTE Modulation of gene expression in cells [35]




AuNPs HeLa, hPSCs Co-electrospinning in vitro MTE Enhanced HeLa cell attachment andpotentiated CM differentiation of hPSCs [37]
PGS/gelatin CNTs CMs Electrospinning in vitro MTE Superior mechanical properties, enhanced CMbeating properties [38]
PLGA + YIGSR neonatal rat CMs Electrospinning in vitro MTE Higher expression of a myosin and b-tubulin,faster and latest longer contraction of CMs [39]
PLGA + SF + Aloe
Vera CMs Electrospinning in vitro MTE
Increased cell proliferation and enhanced
cardiac expression proteins [40]
PCL CNTs H9c2 3D-printing in vitro MTE Cell proliferation [41]
GelMA hciPSC-CMs, -SMCs, -ECs 3D-MPE in vitro MTE
Potentiated cell viability, electromechanical
coupling in vitro, improvements in cardiac




PEGDA hydrogel Human CPCs Microstereolithography in vitro MTE
hCPCs differentiation and 3D spatial
orientation, activation of connexin 43
expression
[43]





in vitro MTE Suitability for the growth and proliferation ofcardiomyoblasts [45]
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Table 1. Cont.
Material NM Cells Approaches/Method ofAssembly Specific Application Biological Effects Ref.
Alginate AuNW CMs and fibroblasts Ionic crosslinking in vitro MTE Improved electrical connectivity andfunctionality [46]
ECM Lap-AuNPs CMs Decellularization process in vitro MTE
Effective cardiac protein expressions and
phenotype maturations of cardiac specific
proteins on the CMs
[47]
Chitosan Se-NPs H9c2 Film preparation in vitro MTE
Attachment and proliferation of H9c2 cells,
functional electrical connectivity between
heart cells and films
[48]
PEG/Chitosan TiO2 NPs neonatal rat CMs Chemical crosslinking in vitro MTE Adhesion, elongation and spreading of cells [49]
PCL + azacytidine CNTs Human MSCs Electrospinning in vitro MTE In vitro cardiac differentiation of hMSCs [50]
PLGA CNF Human CMs Film preparation in vitro MTE Increased CM growth, increased conductivityof the composites [51]
CAu-PLGA NPs Double emulsion solvent
in vivo drug delivery
for cardiac
anti-ipertrophy
Improved survival rate and in vivo cardiac
ant-hypertrophy [52]
Cellulose + CS/SF AD-MSCs Electrospinning in vitro MTE Reduced ventricular remodeling post-MI [53]
PLLA CPCs Sugar template, freezedrying in vitro MTE
Cell extension, growth and differentiation
towards desired lineages in vitro, larger
number of living cells
[54]
PCL:PGA CPCs Electrospinning in vitro MTE Cell attachment and differentiation in vitroand support living cells in vivo [55]
GelMA CNT neonatal rat CMs Hydrogel preparation, UVirradiation in vitro MTE
Transmission of action potential between cells
and synchronous spontaneous beating [56]




GelMA, PEG CNT neonatal rat CMs Microelectrode array,photolitography in vitro MTE
Enhanced electrical synapse formation and
electrical coupling [58]
NM–nanomaterials; PS–Polystyrene; PGS–Poly (Glycerol Sebacate); AM-MSCs–amniotic membrane-derived mesenchymal stem cells; ESCs–embryonic stem cells;
PHB–Poly(3-hydroxybutyrate); MSCs–Mesenchymal stem cells; CMs–cardiomyocytes; CFs–Cardiac fibroblasts; PLGA–Poly(lactic-co-glycolic acid); BSA/PVA–Bovine
Serum Albumin/Poly(vinyl alcohol); PMGI–Polymethylglutarimide, CNT–Carbon nanotube; YIGSR–Tyr–Ile–Gly–Ser–Arg; SF–Silk Fibroin; PCL–Poly(ε-caprolactone);
GelMA–Gelatin-Methacryloyl; SMCs–smooth muscle cells; ECs–Endothelial cells; MPE–multiphoton-excited; PEGDA-Wp–Poly(ethylene glycol) diacrylate woodpile;
EDC-NHS–1-ethyl-3-(3-dimethyl aminopropyl)-carbodiimide/N-hydroxysuccinimide; PLLA–Poly(L-lactic acid).
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Laser-based techniques are alternative and promising approaches to modify a variety of materials
by writing directly the predefined surface geometry at micro and nano scale. Laser ablation was used on
biological scaffold (agarose) inducing improved attachment and differentiation of C2C12 myoblasts [31].
The same method was used for the production of multi-layered elastomeric scaffolds having an
accordion-like honeycomb structure in order to replicate the native myocardium microenvironment
and anisotropy of the left ventricular tissue [32,33].
Plasma surface functionalization was used in combination with other techniques to improve the
hydrophilicity of a surface and spreading, myofibril development and gene expression of primary
neonatal rat CMs and human iPSC-CMs on synthetic, such as poly(lactic-co-glycolic acid) (PLGA),
poly(ε-caprolactone) (PCL), poly(3-hydroxybutyrate) (PHB), and nanofibers (NFs), or biological
substrates, such as fibronectin, for cardiac tissue engineering [34,35,59].
Recently, a great interest was focused on the use of electrospinning to develop scaffolds based on
electrospun NFs with controlled diameters able to replicate the myocardium ECM. Electrospinning
offers the potential of fabricating composite materials of natural and synthetic polymers that can be
implemented with gold nanoparticles (NPs) [36,37] and carbon nanotubes (CNT) [38] to improve
the conductivity of the construct as well with peptides [39] and growth factors [40] to improve the
remodeling and viability of CMs. This technique was even applied with living cells, and a recent study
reported primary neonatal CMs electrospinning to realize living constructs while preserving their
functionalities [39].
Additive manufacturing, known as 3D printing, has recently rapidly evolved as a remarkable
approach in tissue engineering to realize scaffolds, devices and 3D structure including complex organ
like heart [18]. Bioprinted constructs were prepared using alginate and human CM progenitor cells,
demonstrating cell viability, retention of cardiac lineage, enhanced expression of genes and early
cardiac transcription factor sarcomeric protein. A further example of bioprinted scaffold was obtained
by combining hyaluronic acid/gelatin with human fetal CM progenitor cells, with the aim to serve as a
cardiogenic patch. A cardiac patch produced using cell printing of human umbilical vein endothelial
cell and human MSCs on a defined surface, after in vivo implantation in a murine model, showed
increased vessel formation and integration into the murine vascular system, with a possible benefit in
AMI treatment. Bioprinted cardiac constructs using alginate and human coronary artery endothelial
cells were used for in vivo studies offering a high cell viability and distribution, and a good agreement
with the in vitro results in terms of impedance or mechanical behaviour [22]. PCL printed scaffolds
using a microextrusion 3D printer were produced by introducing wirelessly controlled electrical
stimulators, the effect of electrical stimulation improved the attachment and induced differentiated
actin cytoskeletal structures. PCL 3D printed scaffold modified with CNT was used to improve H9C2
viability respect to not modified scaffold [41]. Stereolithography was used for fabricating an innovative
scaffold, based on photoactive gelatin polymer, where CMs, smooth muscle cells and endothelial cells
(ECs) derived from human iPSCs were seeded [42]. This human iPSCs–derived cardiac muscle patch
was evaluated in a murine model of MI showing improved cardiac function and reduced infarct size
after AMI [43]. Moreover, a 3D poly(ethylene glycol) diacrylate (PEGDA) based scaffold obtained
by micro-stereolithography promoted human cardiac progenitor cell differentiation and orientation,
3D spatial ordered orientation, and activation of the expression of α-sarcomeric actinin (α-SA) and
connexin 43 (Cx43).
In combination with micro-nanofabrication, a relevant advancement is represented by the
microfluidic technology that has the potential to overcome the limitations of static culture systems by
reproducing complex cardiac human disease models in vitro, developing drug screening platforms and
controlling physico-chemical and electro-mechanical conditions of specific cell co-cultures (according
the approach named “heart on a chip”) [60,61].
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3.2. Nanomaterials for Cardiac Patches
The use of NPs to modify the scaffold surface is an emerging strategy to improve and implement
various functionalities for complex engineered tissues.
Nanoparticles mimic the physiological nanometric size of ECM components of tissues and their
reduced size accompanied by large surface-to-volume ratio share similarity with peptides or small
proteins. Mimicking the architectural organization of the native ECM, nanomaterial acquires also some
functional properties of ECM. Nanostructures can be incorporated into organic or inorganic materials,
thus improving the properties of the resulting composite nanomaterials and acquiring instructive cues
(Figure 2b).
3.2.1. Inorganic Nanoparticles
The incorporation of inorganic nanoparticles, having suitable properties of biocompatibility and
electro-conductivity, into a scaffold can provide a series of advantages to a cardiac patch including:
(a) increased electro-conductive properties, (b) improved cell compatibility, (c) a biomimetic surface
topography, and (d) increased mechanical stability.
AuNPs represents an emerging class of nanosystems for cardiac tissue engineering due to
its numerous advantages in terms of anti-cardiac hypertrophy effect, biocompatibility, electrical
conductivity, and chemical stability. AuNPs present high electrical conductivity, variety of geometry
(i.e., nanospheres, nanorods, nanowires), intrinsic optical properties, ease of surface functionalization
and a suitable cytocompatibility. For this reason, AuNPs were incorporated into different biological
and synthetic matrices and their physico-chemical and biological effects on scaffolds after seeding with
cardiomyoblasts or CMs were evaluated, as reported in the following studies.
Nanomodification with inorganic particles (gold particles) of ECM/silk fibroin (SF) and MSC
offered a new patch suitable for cardiac tissue engineering. The distribution of homogeneous AuNPs
demonstrated to provide favourable conductivity, in vitro enhanced cell compatibility, retention of CM
survival and in vivo decreasing of infarct size from 89% to 65% in the control group [44].
AuNPs were conjugated to cholecyst derived xenogenic ECM, by means 1-ethyl-3-(3-dimethyl
aminopropyl)-carbodiimide/N-hydroxysuccinimide method. The modified scaffold allowed the
growth and proliferation of the cardiomyoblasts (H9c2 cells) and the introduction of AuNPs provided
a conductivity property to the scaffold useful for improving cell communication and controlling the
polarity of cells [45].
The incorporation of gold nanowires (NWs) within alginate scaffolds increase the electrical signal
propagation among pore walls of alginate and improve electroconductivity and functional of cardiac
cells towards a suitable organization of cardiac tissue [46].
A combination of AuNPs and laponite NPs loaded into myocardial ECM improved cell
compatibility and phenotypes maturation of cardiac specific proteins, enhancing the cell expression of
cardiac specific markers, such as cardiac troponin (cTn) I and Cx43 [47].
Recently, an interesting class of nanoparticles, Selenium NPs, was investigated for its ability to
transfer electrical signals in seeded scaffolds. Selenium NPs are naturally present in human body with
benefit in terms of biocompatibility. Furthermore, many cardiac patients have low level of selenium in
blood, thus their use can be beneficial also for their therapeutic potential after cardiac surgery.
Selenium NPs, obtained by a novel one-pot green synthesis, were used to modify chitosan film; a
recent study confirmed the potential of substrate modified with these nanoparticles to provide electrical
conductivity (0.0055 S cm−1) in order to promote rapid electrical coupling between CMs, and enhance
mechanical properties in agreement with those of native myocardium [48].
Among different categories of nanoparticles, titanium dioxide (TiO2) NPs have received great
attention in biomedical field for their biocompatibility, good physico-chemical properties, biological
stability, and protein adsorption. The introduction of TiO2NPs into a hydrogel matrix can regulate the
mechanical, swelling and degradation behavior by improving the properties of hydrogels for use in
tissue engineering.
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In a recent study, TiO2NPs were homogenously dispersed in PEGylated chitosan hydrogel
demonstrating their capability of improving mechanical and swelling properties and also inducing
cell adhesion and organization of CMs suggesting an efficient use of these nano-modified hydrogel as
cardiac patches for cardiac tissue repair [49].
Carbon nanotubes are widely used in tissue regeneration for their morphological, physico-chemical,
and mechanical properties, but mainly for their tunable conductivity depending on the CNTs
nanostructure. The two following examples show how electrical, topographical, and mechanical
properties of carbon nanomaterials can stimulate MSC differentiation or CMs adhesion and proliferation
on nano-modified cardiac patches.
Electrospun scaffolds of PCL with CNTs were developed to promote the in vitro cardiac
differentiation of human MSCs. An improved human MSC cardiomyogenic differentiation was
obtained due to intrinsic electrical stimulation of CNT in the presence of 5-azacytidine [50].
The incorporation of carbon NFs into a scaffold of PLGA was used to realize a nano-reinforced
cardiac patch where CMs showed an increased ability to adhere and proliferate. The effect of carbon
NF nanotopographical features increased protein adsorption capacitance, thus forming a composite
resembling native heart tissue [51].
3.2.2. Inorganic-Organic Nanoparticles
Specific combinations of inorganic (i.e., AuNPs) and polymeric nanoparticles, allow the realization
of a unique complex nano-system having a large repertoire of properties including the possibility of
releasing, in a controlled way, therapeutic agents able to locally treat cardiac disease.
The use of synthetic polymers (i.e., aliphatic polyesters, polyethylene glycol) and biological
polymers (i.e., chitosan, alginate, gellan) offers important advantages, higher than inorganic components,
in terms of biocompatibility, biodegradability, ease of processing, and functionalization with many
drugs or growth factors.
Polymeric nanoparticles can be obtained by a series of methods including emulsification, solvent
evaporation, precipitation polymerization. Recently, curcumin capped AuNPs on PLGA were prepared
by double emulsion–solvent evaporation method, these nanosystems demonstrated an efficient
curcumin drug carrier for improved cardiac anti-hypertrophy activity in a rat model of induced cardiac
hypertrophy [52].
3.2.3. Polymeric Nanofibers
Non-biodegradable polymers, like polyacrylonitrile, can be processed by electrospinning to
obtain aligned-orientated NF electrospun patch. This NF patch was used as a 3D scaffold to align
the injected rat neonatal CMs and EC [62]. In vivo testing demonstrated that the cell-seeded cardiac
patch after implantation after two months post-MI showed a reduction in infarct size and fibrosis, and
improvement in cardiac function and cardiac haemodynamic parameters.
NF patches of cellulose fabricated via electrospinning were modified with chitosan/silk fibroin
(CS/SF) multilayers obtained via layer-by-layer coating. The patches engineered with adipose
tissue-derived mesenchymal stem cells were applied to the epicardium of the infarcted region in rat
hearts. These patches demonstrated to promote the functional survival of engrafted SCs and reducing
ventricular remodeling post-AMI through attenuating myocardial fibrosis [53].
PCL nanotubes obtained using electrospinning were used to fabricate porous patch for human
MSC differentiation. In addition to induce electroconductivity PCL patch were modified with CNT.
Nanoscale design was applied to many synthetic biomaterials to closely mimic the ECM. For
example, NF poly(L-lactic acid) (PLLA) matrix support cardiovascular progenitor cells growth
and differentiation in 3D for cardiac tissue formation [54]. PCL and poly glycolic acid (PGA) NF
scaffold with various PCL/PGA compositions. These scaffolds facilitated cell attachment, extension,
and differentiation in vitro, and supported living cells expressing the key cell marker proteins of
cardiomyocytes, smooth muscle cells and ECs in a mouse subcutaneous implantation model [55].
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In general, synthetic or biological polymeric biomaterials, in the form of cardiac patches, can help
cells to organize into functional tissue but, due to their intrinsic poor conductivity, limit the ability of
the patch to contract. For this, a polymeric patch has to be reinforced or embedded with conductive
nanomaterials using different methods to transform it in a conductive material [63].
There are some important electroactive polymers, such as polypyrrole (PPy), polyaniline (PANI),
and polythiophene (PTh), which have demonstrated their potential as scaffolds and patches in cardiac
tissue engineering. However, there are some important questions that need to be better investigated
regarding mainly the biocompatibility, biodegradability, and capability of these biomaterials to be
modified. Therefore, the use of electrically conductive nanostructured materials in cardiac tissue
engineering requires more investigation involving an interdisciplinary approach [64].
Importantly, the use of polymeric nanomaterials to modify cardiac patch has to be considered, not
for their possible electroconductive function but for their importance as drug delivery systems to treat
myocardial ischaemia. A recent study demonstrated that NPs, based on deblock copolymers of PEG
and poly (propylene sulfide) (PPS), loaded with ginsenoside Rg3, after intramyocardial injection in
rat ischaemia-reperfusion model, improved the cardiac function and reduced the infarct size due to
released Rg3 action in inhibiting oxidative stress, inflammation, and fibrosis [65].
An effective and multifunctional approach to treat myocardial ischaemia-reperfusion was
developed by introducing relevant doses of a cardioprotective drug (adenosine) into multi-layered
scaffolds having cardio-inductive properties on stem cells [66]. The further encapsulation of
adenosine-core shell polymeric NPs into polymeric scaffold was implemented for a targeted controlled
release of cardioprotective drug to improve the reperfusion injury treatment [67]. Intelligent polymeric
NPs able to recognize a specific ECM metalloproteinase were also evaluated to modify cardiac scaffolds
with the aim to prevent left ventricular dysfunction after AMI [68].
4. Cardiac Stem, Precursor and Differentiated Cell Interactions with Nanoengineered Materials
The evidence that SC interaction with nanoscale surface topography induced cell behaviour
modification, made this interaction to become the principal topics in the future for both nanotechnology
and SC research. Thus, tissue regeneration and function may be properly influenced by scaffold with
nanoscale surface topography.
The addition of nanomaterials can modify the physical and biological properties of the scaffold.
Thus, different hybrid scaffolds containing various types of nanomaterials, with mechanical and/or
electroconductive properties, have been created aimed at studying their effect on structural organization
and functionality of various types of SCs and precursors (Figure 3).
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4.1. Effect of Nanoengineered Materials on Cell Adhesion and Proliferation
A primary role in regulating cellular proliferation and adhesion has been attributed to the
architecture at nanometre scale (Figure 3a). In particular, Bauer et al. pointed out that the cell response
depends on the size of nanotubes. In fact, these authors reported that the greatest MSCs activity
was observed on the layers formed by TiO2 nanotube with 15 nm in diameter. Moreover, comparing
different coating of nanotube surface, the authors concluded that nanoscale surface topography of
materials dominates over surface chemistry effects on MSC adhesion and proliferation [69]. Moreover,
the proliferation rate of both MSCs and ECs decrease with the increase of TiO2 nanotube size [69,70]. In
fact, after 72 h, MSC numbers strongly increased on 15 nm compared to 100 nm nanotubes diameter [69].
In another study, when cultured on anisotropic nanopatterned patch, the proliferation of multipotent
cardiac progenitor cells (CPCs) increased, as confirmed by an increase in the expression of the marker
of proliferation Ki67 [71]. Despite several works which reported that nanotopographical features
of the matrix increases cell proliferation, most of the studies simply observed the enhancement in
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proliferation without explaining neither the predominant feature required nor the signalling pathway
leading to this biological effect.
Since it is well known that cell adhesion is weaker on soft substrate compared to stiffer ones [72]
the nanostructured PEG hydrogel determines weak increase in neonatal CMs adhesion to the substrate,
despite non-adhesive nature of bare PEG hydrogels. The nanopillar topography of PEG favoured
cell–cell interactions with consequent cell aggregation and growth. In fact, the softer surface
of nanopillar PEG promotes growth compared to the stiffer surface of bare PEG that promotes
migration [73].
Culture of CPCs on NF scaffolds made up of PCL and PGA with various proportion evidenced the
highest cell adhesion and proliferation on the synthetic scaffold with 65:35 PCL:PGA ratio, ascribing
this effect to the enhanced hydrophilic properties. Whereas an increase of more than 50% in PGA
showed a gradual reduction in cell adhesion and proliferation because of hydrophobic feature [55].
Another study on scaffolds made up by different ratios of PLGA and CNF highlighted that changes in
composition can drive cell differentiation towards different tissues [74].
On the other hand, Wickman et al. demonstrated that the adhesion of CPCs was affected by the
structural characteristics of the patches rather than by their composition. Indeed, when PCL was
fabricated as sheets there was no CPC adhesion even if the PCL was integrate with thiophene-conjugated
CNT, while when PCL was produced as fibrous meshes by electrospinning there was adhesion and
proliferation of CPC [75]. It should be underlined that PCL sheet alone is a hydrophobic polymer
with little biological activity and the addition of thiophene-conjugated CNT did not improve it. This
flat sheet did not allow the retention of the cells, while the 3D scaffold obtained by fibrous meshes
made by PCL increased it. Moreover, adhesion and retention of the cells were more marked with
the addition of thiophene-conjugated CNT. However, CNT-PCL favoured CPC proliferation with
maintenance of immature phenotype as receptor tyrosine kinase (c-kit) and insulin gene enhancer
protein 1 (Isl-1) expression was demonstrated [75]. CNT-PCL composite scaffolds increased also the
adhesion of human MSCs [50].
To improve the effectiveness of the nanomaterials, the mechanical properties were integrated
with the electrical one. The addition of CNT into Gelatin-Methacryloyl (GelMA) hydrogel promoted
adhesion, retention, and viability of neonatal CMs which were not observed on pristine one [56].
A strong cells adhesion has been observed with graphene oxide (GO)-GelMA compared to GelMA
alone [76]. Furthermore, these authors observed a rise in SC adhesion when GO was partially reduced.
An additional enhancement of cell adhesive properties was also observed when GO was coated with
a natural polypeptide poly L-lysine (PLL). Nanoparticle shape affected focal adhesions number and
size thus determining cell adhesion strength [77]. However, it must be taken into account that each
component added to the scaffold can affect its properties. For instance, the addition of PLL to GO
reduced the conductance of GO.
Also, gold nanorod (NR)-embedded hydrogels induced an increase in stiffness of the scaffold
leading to an enhancement in neonatal CMs adhesion, with formation of tissue layer integrated with
the scaffold [78]. Comparing the addition of various concentrations of AuNR to GelMA, cell retention
and adhesion increased with the highest concentrations. The authors asserted that matrix stiffness
influences cell behaviour, but the conductive component exerted a pivotal role in improving cell
adhesion and retention. Higher AuNR concentration in the hybrid construct induced an enhancement
in β1-integrin expression that favoured their ability to adhere, thus confirming cell–matrix interaction
is mainly mediated by β1-integrins.
The nanotopography of biomaterials seems to be the most important cue for cell adhesion and
proliferation. Moreover, the control of some other features of the nanomaterial such as stiffness,
hydrophilicity and anisotropy can still influence (improve or lessen) the interaction between cells
and nanomaterial surface. With a few exceptions, the addition of conductive component to the
nanostructured matrix can enhance even more the ability to adhere, likely increasing the integrins that
usually mediate cell adhesion.
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The enhanced adhesion of neonatal CMs on CNT-integrated collagen scaffold was accompanied
by an increased expression of disc-related protein with consequent enhanced intercalated disc assembly
and functionality among the CMs. This property may be important for the integration with the host
tissue [57]. It is already known that intercalated discs are composed by three different components:
adherens junctions are specialized in the transfer of contractile forces between cells, desmosomes are
specialized in cell-to-cell adhesion and gap junction are specialized in the transfer of impulse between
neighbouring cells. The authors unveiled the pathway that triggers the increased formation of these
intercellular structures that are a feature of myocardial tissue. In fact, they showed a pivotal role
of β1-integrin-mediated RhoA signaling pathway in the formation of mechanical junction such as
adherens junctions and desmosomes were attributed to [79].
4.2. Effect of Nanoengineered Materials on Cell Morphology
Initially, the alignment and elongation of the neonatal CMs within the 3D hydrogel scaffold was
induced with electrical and/or mechanical external stimulation [12,14,80,81]. More recently, it was
pointed out that alignment of NFs mimics the anisotropic structural organization of myocardium [82]
and the addition of well orientated nanostructures, such as nanofibers or nanotubes, in 3D scaffold
allowed to reach the alignment and elongation of the cells without external stimuli (Figure 3b). In fact,
3D patches with PLGA-NF alignment, that mimics the decellularized ECM of rat cardiac tissue, showed
that human iPSC-CMs cultured on it are aligned with the same direction of NFs in contrast to the
random distribution of iPSC-CMs in 2D culture [83]. An alignment was also observed in neonatal CM
cultured on alginate NW scaffold, while rounded shape cells formed aggregates when cultured on bare
alginate [46]. When cultured on CNT-collagen hydrogel [57] as well as on CNT-GelMA [77], neonatal
CMs showed enhanced cell elongation and morphology alignment leading to a well-organized tissue
formation. Another study was focused on the orientation of the neonatal CMs by the assessment of
the angle between cellular long axis and the direction of aligned NFs inside a 3D GelMA scaffold. It
is relevant that the alignment and the elongated morphology of the cells was still maintained after
6–12 h of enzyme (lipase) activity which disrupted the nanoscale component (only micrometre-scale
was observed by SEM) [84]. The acquired cellular distribution and morphology can favour cell–cell
coupling that is fundamental for tissue engineered functionality.
Native myocardium is composed by multiple layers. A similar structure can be achieved in highly
organized 3D construct using the layer-by-layer assembly technique, that consists in the deposition
on cell surfaces of nanometre-thick films which works as an inter-layer spacer for the layer-by-layer
assembly [77]. Nano-films can display different physical and biological properties depending on
the components.
It must be taken into account that in each layers CMs are uniformly aligned in native myocardium,
while there is a gradual transition in orientation of the aligned cells among the layers. On the basis of
these facts, a precise orientation is required for suitable mechanical properties in cardiac regeneration.
Wu et al. claimed that a 3D multilayer construct with properly differently orientated cells could
be beneficial for cardiac regeneration. In fact, they attempted to overcome this limitation trying to
reproduce the structure of the native cardiac tissue. Since the authors could control cellular orientation,
they realized a 3D construct assembling two monolayers, with orthogonal cellular orientation with
respect to each other, previously encapsulated into a GelMA hydrogel shell [84]. This work demonstrates
the great potential of anisotropic nanostructures. However, in regenerative medicine, the limitation
of an engineered multi-layered 3D tissue is its insertion in the cardiac tissue, because it is difficult
for the orientation of each layer of the 3D construct to precisely reflect the orientation of the native
cardiac cells.
4.3. Effect of Nanoengineered Materials on Cell Differentiation
The nanocomposite hydrogels obtained by CNT incorporation into collagen, provided an
instructive extracellular microenvironment that favoured brown adipose-derived stem cells (BADSCs)
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proliferation and differentiation as demonstrated by the expression of cardiac transcription factors
GATA-4 and Nkx2.5 as well as sarcomeric proteins: cTn T, α- and β-myosin heavy chain (α-MHC,
β-MHC), and α-SA, at day 21 [85]. Also, embryoid bodies increased their cardiac differentiation
(i.e., increased expression of Tn T as well as of the cardiac genes Tnnt2, Nkx2-5, and Actc1) when
cultured in the microwells fabricated on a scaffold obtained by the addition of CNT to GelMA [25].
CNT-GelMA hydrogel promoted maturation of neonatal CMs, which was not observed on pristine
one [56]. After two weeks, iPSCs cultured on gelatin-coated 3D PCL-NF scaffold spontaneously
differentiated, without any exogenous stimulation, towards cardiac lineage as demonstrated by the
increase in cardiac marker expression such as cTn T, cardiac myosin light chain (MLC) and α-SA.
The authors highlighted that, in the early phase (d0-3), this differentiation process was mediated by
Wnt/β-catenin signalling pathway [17]. On the other hand, Sun et al. suggested that the cardiac
differentiation of BADSCs was due to a β1-integrin-mediated transforming growth factor-β1 (TGF-β1)
signaling pathway [85]. Nanomaterial-induced differentiation of various cellular types towards cardiac
lineage [17,24,46,69,75,77,85] via the expression of specific proteins which allow stem cells to acquire a
morphology and function typical of the mature phenotype (Figure 3c).
Lee et al. compared the effect of GelMA hydrogels embedded with three different carbon-based
NPs. In particular, GO and reduced GO showed similar shape but varied in surface chemistry and
conductivity while CNT and reduced GO have comparable conductivity but showed different shapes
and surface area. An electrophysiology study (after patch-clamp) pointed out a difference on neonatal
CM phenotype and maturity among the three different substrates. It is likely that different compositions
of the three substrates create various microenvironments which trigger a different neonatal CM response.
In fact, only the neonatal CMs seeded on CNT-GelMA assumed a ventricular-like phenotype. The
GO-GelMA induced an atrial-like phenotype, while reduced GO-GelMA generated a mixture of the
two phenotypes [86]. We can state that this study clearly highlighted that conductive materials affect
the cell behaviour and play an important role in cell fate.
This study pointed out that although the electroconductive materials favoured the differentiation
towards cardiac lineage, the chosen substratum could strongly influence the result. These results seem
to indicate that CNT-GelMA is more suitable for cardioregeneration, since after myocardial infarction
usually a ventricular damage occurs. Moreover, this study underlines the importance of a deeper
functional investigation that could add more information on the phenotype of the cells in order to
achieve the goal of cardioregeneration.
Several authors have shown an initial organization of sarcomeric protein in sarcomeres. Neonatal
CMs cultured on CNT-GelMA exhibited a remarkable striation of F-actin [76]. CNT-PCL composite
scaffolds increased differentiation of human MSCs, indeed in these elongated cells the sarcomeric
protein MHC and F-actin are strongly colocalized [50]. In another study, neonatal CMs cultured on
CNT-loaded collagen hydrogels showed sarcomeric structures with well-defined anisotropic and
isotropic bands and massive actinin striation compare to collagen hydrogel alone [79]. When cultured
on aligned NFs-embedded GelMA scaffold, neonatal CMs acquired clearly orientatedα-SA and showed
increased sarcomere length compared to the control [84]. The electric conductivity of GO in MSCs
induced a gene expression increase of early marker GATA-4 as well as of the contractile proteins
(i.e., MHC, MLC, and cTn T). While GATA-4 decreased with the culture time, a further up-regulation
of sarcomeric proteins was present at week 3. However, MSC cultures on double- and triple-layer
graphene did not exhibit an additional increase in cardiomyogenic gene expression. Since MSCs did
not exhibit the functional and electrophysiological properties of mature CMs regardless of the substrate
type, the authors suggested that additional signals may be required to differentiate MSCs into mature
CMs, like graphene [87]. Thus, it seems that the addition of electroconductive nanomaterials induced
also a more pronounced differentiation towards cardiac lineage of various cellular types cultured on
them, though it should be kept in mind that the degree of differentiation achieved depended also on
the type of SCs involved in the study. In fact, the increased expression in cardiac markers matched
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with the enhanced level of Cx43, a membrane protein involved in cell–cell coupling, as evidenced in
the next subsection.
4.4. Effect of Nanoengineered Materials on Cellular Electrical Coupling and Conduction of the Impulse
Connexins are proteins involved in the intercellular junctions called gap junction. In fact, gap
junctions are formed by the proper docking of two connexons that in turn are composed by hexameric
assemblies of connexins. Among the different isoforms, the main one is Cx43. These structures,
localized at the intercalated disc of the CMs, allow the passage of ions form one CM to the next one.
After cell isolation, Cx43 is lost or internalized into the cell, thus limiting the electrical coupling
with adjacent cells and consequently the proper cell–cell transfer of the electrical signal, function that
is essential in the cardiac tissue.
To achieve the highly beneficial effect of electrical property enhancement, which is fundamental in
cardiac applications, AuNPs were deposited in decellularized scaffolds composed of a fibrous matrix.
Neonatal CMs seeded on this scaffold showed up an increase in Cx43 [88,89]. The expression of Cx43
was also increased in MSCs cultured on GO [87].
The cellular distribution of this protein is most relevant for an adequate transmission of electrical
signal between cells, thus improving engineered tissues function suitable in MI treatment. Cells
cultured on various AuNP scaffolds showed that Cx43 is especially localized aligned between adjacent
neonatal CMs while its expression is weaker and randomly distributed in cells cultured on pristine
scaffold [88,90]. The distribution of Cx43 in membrane is essential for a synchronized electrical signal
propagation, typical of cardiac tissue. Incorporation of AuNWs in alginate scaffolds augmented
electrical properties of the scaffold and facilitated transmission of the electrical signal. When neonatal
CMs interacted with NWs-integrated scaffold, the engineered tissue showed a faster and synchronized
electrical activity [46,56]. On the contrary, pristine scaffold showed negligible signal conduction among
cells, even after external stimulation [46]. On the other hand, alginate films containing AuNRs, instead
of NWs, exhibit similar topographic features, but a negligible electrical current was measured [46,56].
All together these results demonstrate an essential role of electroconductive materials in the signal
propagation, accompanied by an increased expression as well as by a change in distribution of Cx43
(Figure 3d).
Other groups observed spontaneous electrical activity in neonatal CMs grew on CNT-laden
scaffold, with a consequent cell–cell coupling improvement [56,91]. Martinelli et al. highlighted that
the addition of CNT to the scaffold changed the electrophysiology of the cells. In particular, neonatal
CMs cultured on CNT-scaffold exhibited a more negative resting potential that was closer to that of
mature CMs [91] and the authors attributed this cell maturation to the interaction of neonatal CMs
with CNT.
Using AuNWs as conductive materials within 3D porous scaffolds, neonatal CMs exhibited
enhanced electrical coupling and later on growth of cardiac muscle cells was observed and resulted in
electrical synapse formation [58].
Shun et al. studied the signaling cascade that brings to the enhancement in Cx43. The
authors demonstrated that the formation of gap junction occurred via the activation of the
β1-integrin-mediated focal adhesion kinase - extracellular signal-regulated kinase - GATA-4
transcription factor (FAK/ERK/GATA-4). This pathway triggered by β1-integrin should be studied
with different conductive materials to confirm its role. Therefore, conductive nanomaterials notably
hasten gap junction formation, thus providing the cues for the spreading of the impulse into the cardiac
tissue, a key activity in cardiac function [85].
4.5. Effect of Nanoengineered Materials on Cell Contractility
Effective cell–cell communication among adjacent cells is important for cardiac tissue contraction.
It is well known that myocardial function is a consequence of electro-mechanical coupling that allows
to convert the cellular electrical excitation in mechanical contraction. In fact, the propagation of
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excitation (i.e., action potential) through gap junction to neighbouring cells cause an increase in
cytosolic Ca2+ level. The binding of Ca2 to cTn C activates the sliding of sarcomeric proteins that
lead to cell contraction. Yet, a proper correlation exists between the structure and the function of the
myocardium, indeed the cardiac fibres can twitch only if the sarcomeric proteins give rise to sarcomere
structures (Figure 3e).
Since the myocardium must contract simultaneously, i.e., as a syncytium, it is essential that the
contraction is preceded by the spreading of impulse throughout the gap junctions. An enhancement
of intercellular connection between aligned neonatal CMs, due to the increase in Cx43 expression,
together with the improvement of sarcomere structure, are essential for the contractile property of
the heart. Indeed, along with a higher expression of cardiac markers (such as cTn I, α-SA, and Cx43),
neonatal CMs cultured on alginate NW exhibited a synchronous contraction after stimulation [46] and
synchronous spontaneous beating, that lasted for more than a week, was shown when the neonatal
CMs were seeded on CNT-laden GelMA [56]. Instead, BASCs cultured CNT-PCL scaffolds beat
spontaneously for up to three days only [85]. Shin et al. attributed the more stable synchronous
beating of the cells to a lower excitation threshold [56]. A reduced excitation threshold was observed
in 124 polymers integrated with CNT [92]. Conversely, the synchronous contraction of the cardiac cells
seeded on AuNP-decellularized matrix occurred applying a lower voltage with an external electrical
pacing [93]. Therefore, the reduction of excitation threshold is not just a feature of CNT.
On the contrary, neonatal CMs cultured on nanopillar PEG generated train of action potentials
with higher amplitude and different morphology compared to control. Surprisingly, beating frequency
was lower than expected: it was similar to the one measured in the bare PEG. The author suggested that
the neonatal CMs beating might be affected by insufficient network formation and/or weak cell–cell
adhesion as well as poor interaction with the substrate [73]. It is likely that an improvement in the
effectiveness of the nanomaterials could be obtained if the mechanical properties were integrated with
the electrical one.
Electroconductive nanomaterials enhanced contractility. Changes in calcium level has been
observed in the case of neonatal CMs cultured on AuNR-GelMA hybrid hydrogel [78]. In particular, a
higher efficiency in calcium cycling has been observed in iPSC due to the presence of aligned NFs in 3D
scaffold [83]. Moreover, calcium transient is essential for the rhythmic synchronous beating of the cells.
Calcium transients were significantly enhanced in neonatal CMs cultured on NWs-loaded alginate
than in alginate alone [46]. Using a green fluorescence dye, the authors demonstrated that applying
an external stimulus to the pristine scaffold the fluorescence remained localized in the stimulation
point, while in the NWs integrated scaffold the propagation of the depolarization occurred and reached
remote areas from the stimulation point [46]. Spontaneous Ca2+ transients with higher fluctuation
and more synchronous rhythm were observed in neonatal CMs cultured on CNT-collagen hydrogel
compared to bare collagen [57]. The enhanced contractility occurred also in neonatal CMs cultured on
cardiac patches formed by CNT-incorporated chitosan-gelatin hydrogels [94]. Interestingly, beating
propagation can be interrupted by heptanol that inhibits the calcium permeability of gap junction
thus inhibiting cell–cell coupling. Beating persisted in cells cultured on CNT-GelMA compared to the
GelMA alone. This persistent activity of the cells in the presence of the heptanol was attributed to the
conductive CNT network which allowed the transmission of action potential between cells [56].
All together these results suggest an important role of electroconductive nanomaterials as 3D
scaffold components, because their conductive property could be helpful in an infarcted area of the
myocardium where necrotic CMs interrupt the propagation of the action potential in the ventricular
tissue, thereby increasing the probability that arrhythmic events occur.
Greater isometric twitch forces were observed in tissue-engineered cardiac patches with a
remarkable degree of CM alignment and electrical anisotropy [90]. It should be kept in mind that, in
native myocardium, the precise orientation of the CMs is essential for an efficient twitch of the heart
during the contraction. In fact, seeded iPSC-CM on decellularized thin slices of myocardium, obtained
from mini pig hearts with a native alteration in ECM due to genetic hypertrophic cardiomyopathy,
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displayed prolonged twitch contractions (due to a prolonged calcium transient) [95]. These authors
highlighted the pivotal role of ECM architecture in tissue engineering, demonstrating how alteration
in myocardial ECM can also alter the contractile behaviour of healthy cells.
4.6. Effect of Nanoengineered Materials on Vascularization
Incomplete vascularisation and poor endothelialization can limit the potentialities of engineered
cardiac scaffolds for regenerative purposes after tissue damage.
It is well-known that blood vessel wall is formed by three different layers: intima, media, and
adventitia, starting from the innermost outwards. Although each layer included at least one precursor
population which can be involved in new vessel formation, it has been reported that growth factors
exerted a relevant role in this process [96] As stated earlier, vascularization is essential to guarantee the
vitality of cardiac tissue and to maintain its function since CMs have high metabolic request. Moreover,
about 30% of cardiac tissue is composed of myocytes, while the remaining 70% are non-myocytic cells
(such as fibroblasts, endothelial and smooth muscle cells) that support the growth of myocytes [97,98].
Engineering multilayer constructs display some limits. In particular, nutrients and oxygen transport
to the cells in the deepest layers are restricted because of the thickness of the in vitro engineered
tissue [99]. It has been reported that in a construct formed by more than three sheets (80 µm thick)
an extensive necrosis occurred [100]. Vascularization of cardiac engineered multilayer tissue could
overcome this critical limit, thus promoting the long-term survival of the artificial tissue, which is a
highly relevant for clinical application in cardiac regeneration (Figure 3f).
It should be born in mind that coronary circulation supports myocardial development not only
via perfusion, but also through paracrine release of various factors/molecules [101]. It is established
that blood vessel formation can occur by (1) angiogenesis which is the sprouting of new blood vessels
from the existing ones and endothelial cells are responsible for the capillary growth, (2) arteriogenesis
that consists of remodelling and growth of pre-existing arterioles for instance by the increase in their
lumen size or (3) vasculogenesis that consists of de novo vessel formation involving the migration,
differentiation and incorporation of endothelial progenitors, normally from the bone marrow, into the
damaged vessels. During ischemia neovascularisation is favoured by autocrine factor release which
activate endothelial cells to respond to exogenous growth factors, in particular vascular endothelial
growth factor (VEGF), fibroblast growth factor (FGF), insulin growth factor (IGF) [102].
Several studies focused their attention on vascularization of constructs, via the functionalization of
NPs with growing factors to induce the formation of vessel network. Tan et al. produced self-assembled
NPs capable of sustained VEGF release to augment vascularization of decellularized scaffolds obtained
from bovine jugular vein [103]. Non-covalent self-assembly properties of heparin with low molecular
weight and N,N,N-trimethylchitosan chloride (TMC) through electrostatic interactions allowed to
obtain NPs able to protect VEGF bioactivity, demonstrating both higher proliferation of ECs and
increased capillary formation rate. In in vitro study by Gonzalez-García group demonstrated that
poly(ethyl acrylate) triggers the assembling of fibronectin into nanonetworks, fibronectin remains in
a globular conformation within the control polymer poly(methyl acrylate). The fibronectin network
allows VEGF binding domains to be exposed, thus promoting vessel formation by endothelial cells in
response to extremely low concentration of VEGF inside the scaffold [104]. Izadifar et al. designed
bilayer polymeric NPs made of different components (PLGA and PLLA/PLGA shell/cored bilayers) in
order to obtain sequential release of angiogenesis factors from a fibrin matrix, platelet-derived growth
factor first followed by simultaneous release of basic FGF and VEGF [105]. Rat aortic ring assay was
used to assess ex vivo angiogenesis and the highest significant rise in the number of endothelial sprouts
was obtained in sequential release group in comparison to simultaneous VEGF-FGF and only VEGF
release groups. In another study, angiogenic growth factors were encapsulated into NF scaffolds, trying
to mimic the complexity of native cardiac ECM architecture, which exhibits a NF-collagenous matrix
with spatio-temporal localization of various growth factors. Lakshmanan’s group highlighted the
efficiency of growth factors embedded NF patch made of two polymers, poly(L-lactide-co-caprolactone)
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(PLCL) and poly(2-ethyl-2-oxazoline) (PEOz) to stimulate EC migration and vasculogenesis in in vitro
study. Moreover, the implant of this dual growth factor-loaded patch in a rabbit having undergone
AMI evidenced blood vessel sprouting in the patch secured region with consequent improvement
of functional regeneration of cardiac tissue [106]. He et al. confirmed that neovascularization was
accompanied by a reduction in infarct size extension as well as cardiac function improvement in an
in vivo study [107].
Since the addition of ECs to CM culture exerted a positive effect on the spontaneous vascularization,
improving cardiac tissue structure and function [101,108,109], other authors developed strategies to
obtain engineered endothelialized cardiac tissues via ECs and CMs coculture on 3D scaffolds. In
particular, adding GelMA shell encapsulating homogeneously ECs network to a single layer 3D scaffold
covered by elongated and aligned CMs, an in vitro vascularized tissue surrogate was obtained [84].
The interaction of ECs with CMs may also promote cell viability and proliferation [101].
Nevertheless, considering the structural and functional hierarchy of coronary circulation of the
native myocardium, neovascularization and its integration in the host tissue remains a great challenge
in tissue engineering.
More attention, however, should be paid to the choice of nanomaterials because some negative
effects have also been reported. For example, diamond NPs and, to a lesser degree, graphite NPs
inhibited angiogenesis [110]. Moreover, TiO2 nanomaterials induced leakiness of blood vessels [111].
AuNPs also caused leakiness depending on the NP size and different sensitivity of endothelial cells
according to their various origins [112].
5. Challenges and Future Perspectives
Tissue regeneration and function may be properly influenced by scaffolds with nanoscale surface
topography. For about three decades, researchers involved in cardiac tissue engineering have been
evaluating the possibility of adapting and implementing several micro and nanofabrication techniques
to produce 3D nanostructured biomaterials in order to provide a native-like template of ECM that
stimulates a proper SC commitment towards cardiac lineage. Indeed, the improvement and/or
acquirement of some biological properties such as proliferation, adhesion, differentiation, mechanical
properties, electrical properties, and vascularisation could be achieved by combining different
nanomaterials, thus taking advantage of their different properties and features. The use of hybrid
materials, based on the combination of organic (i.e., synthetic polymers, proteins, polysaccharides, and
their blends) and inorganic components, provides improved and tunable mechanical and rheological
properties, leading to a better performance of the scaffolds for soft tissue engineering.
These intense studies allowed to define a few important concepts: (i) the nanotopography of
biomaterials seems to be the most important cue for cell adhesion; (ii) the addition of conductive
component to the nanostructured matrix can enhance even more the ability of the cell to adhere
and, certainly, to differentiate; (iii) the chosen conductive substratum can strongly influence the
differentiation result and specific attention has to be deserved to the ventricular-like phenotype;
(iv) conductive nanomaterials is a key component for gap formation and impulse conduction; (v)
well-oriented nanostructure, that mimics the anisotropy of ECM, affects elongation and alignment
of the cells which is crucial for well-organized tissue formation; (vi) beside regeneration, multiple
properties of the nanomaterials, like stiffness, elastic modulus, interfacial adhesion, and particle size
exert an essential and prompt mechanical support for the infarcted myocardium.
The nanomaterials (nanoparticles, nanotubes, or nanofibers) studied in the literature and reported
in this review have shown to have important properties for cardiac tissue engineering, allowing the
implementation of the functions performed by the scaffold alone. Each kind of nanomaterial can
improve a particular function, even if it can sometimes elicit multiple actions, therefore the choice
in its use depends on the main aspect to be improved. In particular, AuNP have been used for their
high thermal conductivity, low toxicity, and capability of enhancing electrical communication between
adjacent cardiac cells. Moreover, various strategies have been already developed to modify their
Nanomaterials 2020, 10, 1587 20 of 28
surface in order to use these nanomaterials also as drug delivery nanocarriers for a controlled release
of specific biomolecules capable of improving proliferation and differentiation of stem cells. The
challenge remains to find a correct spatial distribution of conductive nanoparticles. With respect to this,
nanofibers and nanotubes would favor a greater connection leading to a nano fibrous network that
reduces the electrical impedance of cross-linkable hydrogels. Actually, the main reason for the use of
nanofibers and carbon nanotubes is their efficiency in increasing mechanical strength of scaffold in order
to withstand the high pressures of each heartbeat and volume of blood. The main limit in the use of
metallic or inorganic nanoparticles is their non-biodegradability and possible chronic bioaccumulation
with consequent toxic effects. The use of polymeric nanomaterials and, in particular biodegradable
polymeric nanoparticles, could be beneficial in this sense but they do not possess conductive properties
in order to favor cell differentiation, impulse propagation and cell contractility. To increase electrical
conductivity, the use of electroactive polymers could be very promising, however the greatest challenge
is the potential toxicity and non-degradability of these materials. If we consider the approach of heart
tissue engineering in vivo, the limitations related to the use of permanent electroactive polymers are
even stronger. For this, many efforts in multidisciplinary research have to be addressed to enhance
the mechanical and electrical properties of the scaffold, while maintaining the main requirements of
multifunctional scaffolds in terms of biocompatibility and biodegradability.
Many manufacturing techniques have proven to be suitable for the realization of
micro-nanostructured scaffolds mimicking anisotropic structure of myocardium. However, each
of these techniques presents some advantages and disadvantages. Laser-based techniques, 3D printing
and electrospinning allowed the direct fabrication of 3D scaffolds having different spatial resolution,
using biological and elastomer polymers also in the presence of cardiac progenitor cells, showing
improved cardiac function after in vivo implantation. Moreover, a large number of materials including
biological, synthetic and bioartificial polymeric materials were processed in micro-structured substrates
to be subsequently overlayered to obtain a 3D patch. In recent years, one of the best and most applied
techniques is electrospinning that offers the possibility of recreating the fibrous structures of cardiac
ECM from the nano- to micro-scale. Obtained polymers in form of nanofibers can be assembled in
different forms and implemented with electro-conductive nanomaterials and biochemical signals to
provide the mechanical, conductivity and biological properties of cardiac microenvironment. This
technique consents the control of fiber diameter and alignment, but presents some limitations in
the formation of thicker constructs and consequently in mechanical strength. Recent advances in
fabrication of nanofibers using novel apparatus of electrospinning system could bring addressing
specific issues, in order to manufacturing high- quality 3D scaffolds [113]. Additive manufacturing,
including selective laser sintering and bioprinting, consents to produce a 3D construct on the basis of a
predefined CAD drawing. The resolution depends on the physico-chemical properties of materials
used, laser size and viscosity in the case of hydrogel. However, for some materials, heat generation can
cause deformation of structure profiles or alteration of chemical properties of patch. For this reason,
advances in combinatorial approach of microfabrication techniques can reveal particularly useful to
meet the challenges for a valid in vitro but particularly in vivo cardiac tissue engineering.
In addition, 3D printing of cell-laden soft hydrogels can be considered an emerging strategy to
recreate the native micro-environment by means of a specific composition and positioning of cells
and materials in one step. A 3D printed pre-vascularized stem cell patch was produced using stem
cell-laden decellularized ECM bioinks showing improved cardiac functions as well as reduced fibrosis
and capillary formation [114]. New multicomponent material bioinks including nanoparticles or
inorganic fillers are currently being developed to improve the mechanical resistance and stiffness of
pure hydrogels, to increase the printing fidelity and to elicit desired cell functions for specific tissue
engineering applications [115]. Composite bioinks have already demonstrated great potential for hard
tissue engineering but due to their tunable and personalized properties have been gaining increasing
attention also for soft tissue engineering.
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From a biological standpoint, new insight about the pathways triggered by the interaction of the
cells with the mechanical, structural, and electrical properties of nanomaterials would be helpful to
achieve successful myocardial regeneration. Unfortunately, most studies described just the appearance
of biomolecular or morphological/histological cardiac features, such as the appearance of sarcomeric
proteins or the expression of transcription factors typical of cardiac cells. To date, however, few studies
have revealed the molecular pathways triggered by nanomaterials that cause changes in cellular
behaviour, with the possible exception of the increased cellular adhesion and cell–cell interaction. The
knowledge of pathways involved in other nanomaterial-induced cellular effects, a deeper investigation
on the functional aspects of the 3D engineered cardiac tissue, as well as a definition of the precise
spatial and temporal control exerted by nanomaterials over the physiological phenomena through
real-time monitoring of relevant biological events are very important future challenges.
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